Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash
Transaction drives efficiencies, enhances capabilities and further strengthens Ionis' financial position
Transaction is a key step in the evo... Biopharmaceuticals, Mergers & Acquisitions Ionis Pharmaceuticals, Akcea Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Mergers and Aquisitions | Pharmaceuticals